Tech Company Financing Transactions
Mersana Therapeutics Funding Round
Mersana Therapeutics closed a $5 million funding round on 9/30/2013. Backers included New Enterprise Associates.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
New Enterprise Associates (David Mott)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/30/2013: Ecovative Design venture capital transaction
Next: 9/30/2013: Two Moms in Raw venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs